Abstract: The present invention relates to the use of (-)-(2S,4S)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosine to treat psoriasis, genital warts and other hyperproliferative keratinocyte diseases such as hyperkeratosis, ichthyosis, keratoderma or lichen planus.
Type:
Grant
Filed:
January 26, 1998
Date of Patent:
May 16, 2000
Assignees:
The University of Georgia Research Foundation Center, Yale University